Latest filing published 10 May 2019 for CytoDyn Inc..
Insider track record
Michael A. Klump: trading record in brief
Michael A. Klump discloses dealings in CytoDyn Inc. to SEC (Form 4). Over a trading history stretching from 16 November 2018 to 8 May 2019, the count stands at 10 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 10 May 2019 with a share grant in CytoDyn Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael A. Klump
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,716,666 sharesCommon StockSEC:0000899243-19-013098:5
- 33,333 sharesCommon StockSEC:0000899243-19-013098:6
- 62,500 sharesCommon StockSEC:0000899243-19-013098:7
- 1,000,000 shares@ US$0.4028.6% of flowCommon StockSEC:0000899243-19-013098:0
- 1,933,333 shares@ US$0.4055.2% of flowCommon StockSEC:0000899243-19-013098:1
- 500,000 shares@ US$0.3010.7% of flowCommon StockSEC:0000899243-19-013098:2
- 66,667 shares@ US$0.401.9% of flowCommon StockSEC:0000899243-19-013098:3
- 125,000 shares@ US$0.403.6% of flowCommon StockSEC:0000899243-19-013098:4
- 7,034,520 sharesCommon StockSEC:0000899243-18-029256:0
- 7,034,520 sharesCommon StockSEC:0000899243-18-029191:0
10 of 10 declarations